{"transactions":[{"id":2205919,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":125332,"kind":"person","name":"Berk Gregory","position":1,"cik":"0001306870","reported_name":"Berk Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. of R&D, CMO"}}],"security":"Option to purchase Common Stock","published_at":"2022-07-20T01:44:55.000Z","date":"2022-07-15","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":50000,"derivative":{"exercise_price":2.48,"exercise_date":"2022-07-15","expiration_date":"2032-07-14","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-22-019873","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/109657/000149315222019873/ownership.xml","form_type":"4"}},{"id":2399926,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":125332,"kind":"person","name":"Berk Gregory","position":1,"cik":"0001306870","reported_name":"Berk Gregory","relationship":{"director":true}}],"security":"Option to purchase Common Stock","published_at":"2022-02-14T22:10:00.000Z","date":"2021-02-16","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents a grant of options in connection with the reporting person's services as a director. 13rd of the shares underlying the options vest on February 16, 2021, 2022 and 2023."}],"balance_after":50000,"derivative":{"exercise_price":6.33,"expiration_date":"2031-02-15","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001654954-22-001643","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/109657/000165495422001643/section16.xml","form_type":"4"}},{"id":2399925,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":125332,"kind":"person","name":"Berk Gregory","position":1,"cik":"0001306870","reported_name":"Berk Gregory","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-02-14T22:10:00.000Z","date":"2021-02-16","kind":"grant","acquired":true,"shares":278058,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of shares of restricted stock (\"RSAs\") in connection with the reporting person's services as a director.  1/3rd of the RSAs vest on November 11, 2020, 2021 and 2022.  The reporting person resigned as a director on April 23, 2021."}],"balance_after":278058,"source":{"system":"sec-edgar","filing":"0001654954-22-001643","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/109657/000165495422001643/section16.xml","form_type":"4"}},{"id":4492939,"issuer":{"id":5242,"kind":"organization","name":"Verastem, Inc.","symbol":"VSTM"},"owners":[{"id":125332,"kind":"person","name":"Berk Gregory","position":1,"cik":"0001306870","reported_name":"Berk Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-01-11T17:01:06.000Z","date":"2017-01-09","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option will vest on January 9, 2018 and 6.25% of this option will vest at the end of each successive three-month period thereafter until January 9, 2021."}],"balance_after":150000,"derivative":{"exercise_price":1.2,"expiration_date":"2027-01-09","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001104659-17-001976","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1306870/000110465917001976/a4.xml","form_type":"4"}},{"id":4570654,"issuer":{"id":5242,"kind":"organization","name":"Verastem, Inc.","symbol":"VSTM"},"owners":[{"id":125332,"kind":"person","name":"Berk Gregory","position":1,"cik":"0001306870","reported_name":"Berk Gregory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2016-11-01T20:14:14.000Z","date":"2016-10-29","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On June 14, 2016, the Reporting Person was granted an option to purchase 100,000 shares of common stock.  The option vests based on the Issuer's satisfaction of certain performance milestones by the end of June, 2017 and the end of June, 2018.  50% of the performance criteria was met on October 29, 2016, resulting in vesting of the option as to 50,000 shares."}],"balance_after":50000,"derivative":{"exercise_price":1.37,"exercise_date":"2016-10-29","expiration_date":"2026-06-14","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-16-153855","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1306870/000110465916153855/a4.xml","form_type":"4"}}]}